Upregulation of serum levels of hepcidin, the hepatic hormone regulating systemic iron metabolism, has been proposed to explain the alterations of iron metabolism of CHD patients and the resistance to anemia treatment[5,6]. The gene discussed is HAMP; the disease is coronary artery disorder.